» Share this page

Friday January 29, 2021

As part of today's announcement by the Institut national de santé publique du Québec, Génome Québec is proud to collaborate on the SARS-CoV-2 variant surveillance program for Québec, an initiative of more than $11M bringing together several partners. 

“This collaboration is an extraordinary opportunity to put our infrastructure and our highly qualified personnel at the service of health authorities and the population. Thanks to the massive investments made by the Québec Government and Genome Canada, over the past twenty years, Québec is a leader in genomics. This variant surveillance initiative will put to good use the genomics skills acquired over the years, to provide answers and take leadership on a Canadian scale.” said Génome Québec President and CEO Daniel Coderre.

To read the press release, click here. (In French only)

Back to news list